Latest news
Scholar Rock drops Catalent facility from marketing application for muscle weakness drug - 1470 & 100.3 WMBD1470 & 100.3 WMBD · Sat, 08 Aug 2026 02:32:33 GMTScholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 20:20:00 GMTScholar Rock Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 13:04:04 GMTScholar Rock Reports Second Quarter 2026 Financial Results and Recent Business Highlights - BioSpaceBioSpace · Thu, 06 Aug 2026 12:39:18 GMTNorwood Hospital advocates celebrate legislative steps to reopen facility, note ‘important steps ahead’ - Boston HeraldBoston Herald · Tue, 04 Aug 2026 00:05:54 GMTWichita’s new water facility closer to finish line - AudacyAudacy · Tue, 28 Jul 2026 07:00:00 GMTSouth Africa’s Biovac secures $15 million AfDB loan for Africa’s first end-to-end cholera vaccine plant - Business Insider AfricaBusiness Insider Africa · Mon, 27 Jul 2026 07:00:00 GMT